KORMAN, N.; PASSERON, T.; GORDON, K.; OKUBO, Y.; BAGEL, J.; SOFEN, H.; WARREN, R.; BHATIA, N.; SPELMAN, L.; WINTHROP, K.; HIPPELI, L.; KISA, R.; BANERJEE, S.; THAÇI, D. Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s46, 2022. DOI: 10.25251/skin.6.supp.46. Disponível em: https://jofskin.org/index.php/skin/article/view/1801. Acesso em: 22 jul. 2024.